Shan Ahmed Khan

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Shenzhen stocks reopen Tuesday: what to watch on ChiNext, rates and trade cues this week

Shenzhen stocks reopen Tuesday: what to watch on ChiNext, rates and trade cues this week

Shenzhen stocks come back online Tuesday, following the mainland’s Spring Festival shutdown that kept local markets dark through Monday. That means investors have to catch up, digesting a backlog of global developments all at once. Trading on the Shenzhen Stock Exchange and other mainland venues resumes Feb. 24, as listed on the Stock Connect calendar from Hong Kong Exchanges and Clearing.
22 February 2026
·
EGX30 slides 3% into the weekend as geopolitics bites; Egypt stocks face a Sunday test

EGX30 slides 3% into the weekend as geopolitics bites; Egypt stocks face a Sunday test

Egypt’s EGX30 index closed out Thursday down 2.98%, ending at 50,667.67 points, according to data from EFG Hermes Research. Trading volume reached roughly 5.6 billion Egyptian pounds. Small- and mid-cap indices also tumbled, both shedding about 3%. The EGX30 tracks 30 of the Egyptian Exchange’s most liquid, free-float stocks. Markets remain closed Saturday, with trading set to resume Sunday.
21 February 2026
·
1 … 30 31 32 33 34 … 607

Stock Market Today

  • FTSE 100 Climbs as Oil Slumps; Vodafone, AstraZeneca Boost Index
    July 27, 2026, 3:45 AM EDT. The FTSE 100 added 51 points at the open to reach 10,787, buoyed by Vodafone jumping 3.6% after a positive update and AstraZeneca advancing 1.1% as its Q2 earnings surpassed expectations. Although BP fell 3.7% and Shell slipped 1.9% in response to a drop in oil prices to $91.54 per barrel, strength in banking, mining, and retail stocks supported the broader market. AstraZeneca reported a 21% rise in core EPS to $2.63, coming in ahead of analyst estimates.